90 related articles for article (PubMed ID: 2669990)
1. Prediction approaches to sequentially searching for an optimal dose.
Shih WJ
Biometrics; 1989 Jun; 45(2):623-8. PubMed ID: 2669990
[TBL] [Abstract][Full Text] [Related]
2. Multiple test procedures for dose finding.
Tamhane AC; Hochberg Y; Dunnett CW
Biometrics; 1996 Mar; 52(1):21-37. PubMed ID: 8934584
[TBL] [Abstract][Full Text] [Related]
3. A note on multiple testing procedures in dose finding.
Bauer P
Biometrics; 1997 Sep; 53(3):1125-8. PubMed ID: 9333343
[TBL] [Abstract][Full Text] [Related]
4. Dynamic treatment allocation adjusting for prognostic factors for more than two treatments.
Dror S; Faraggi D; Reiser B
Biometrics; 1995 Dec; 51(4):1338-43. PubMed ID: 8589225
[TBL] [Abstract][Full Text] [Related]
5. Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints.
Jennison C; Turnbull BW
Biometrics; 1993 Sep; 49(3):741-52. PubMed ID: 8241370
[TBL] [Abstract][Full Text] [Related]
6. Dose finding - a challenge in statistics.
Bretz F; Hsu J; Pinheiro J; Liu Y
Biom J; 2008 Aug; 50(4):480-504. PubMed ID: 18663758
[TBL] [Abstract][Full Text] [Related]
7. Group sequential comparison of changes: ad-hoc versus more exact method.
Lee JW; DeMets DL
Biometrics; 1995 Mar; 51(1):21-30. PubMed ID: 7766776
[TBL] [Abstract][Full Text] [Related]
8. On the design and analysis of randomized clinical trials with multiple endpoints.
Tang DI; Geller NL; Pocock SJ
Biometrics; 1993 Mar; 49(1):23-30. PubMed ID: 8513104
[TBL] [Abstract][Full Text] [Related]
9. Continual reassessment method: a likelihood approach.
O'Quigley J; Shen LZ
Biometrics; 1996 Jun; 52(2):673-84. PubMed ID: 8672707
[TBL] [Abstract][Full Text] [Related]
10. A multiple-step selection procedure with sequential protection of preferred treatments.
Chen TT; Simon R
Biometrics; 1993 Sep; 49(3):753-61. PubMed ID: 8241371
[TBL] [Abstract][Full Text] [Related]
11. A group sequential procedure for all-pairwise comparisons of k treatments based on the range statistic.
Liu W
Biometrics; 1995 Sep; 51(3):946-55. PubMed ID: 7548710
[TBL] [Abstract][Full Text] [Related]
12. Causal nonresponse models for repeated categorical measurements.
Conaway MR
Biometrics; 1994 Dec; 50(4):1102-16. PubMed ID: 7786991
[TBL] [Abstract][Full Text] [Related]
13. Dunnett's many-to-one test and least square means.
Shun Z; Silverberg A; Chang CK; Ouyang P
J Biopharm Stat; 2003 Feb; 13(1):17-28. PubMed ID: 12635900
[TBL] [Abstract][Full Text] [Related]
14. Global cross-ratio models for bivariate, discrete, ordered responses.
Dale JR
Biometrics; 1986 Dec; 42(4):909-17. PubMed ID: 3814731
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for monitoring efficacy and toxicity responses in clinical trials.
Cook RJ; Farewell VT
Biometrics; 1994 Dec; 50(4):1146-52. PubMed ID: 7786995
[TBL] [Abstract][Full Text] [Related]
16. Variable selection for clustering with Gaussian mixture models.
Maugis C; Celeux G; Martin-Magniette ML
Biometrics; 2009 Sep; 65(3):701-9. PubMed ID: 19210744
[TBL] [Abstract][Full Text] [Related]
17. A graphical approach to sequentially rejective multiple test procedures.
Bretz F; Maurer W; Brannath W; Posch M
Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
[TBL] [Abstract][Full Text] [Related]
18. Testing for the existence of a desirable dose combination.
Hung HM; Chi GY; Lipicky RJ
Biometrics; 1993 Mar; 49(1):85-94. PubMed ID: 8513112
[TBL] [Abstract][Full Text] [Related]
19. Approaches for optimal sequential decision analysis in clinical trials.
Carlin BP; Kadane JB; Gelfand AE
Biometrics; 1998 Sep; 54(3):964-75. PubMed ID: 9750245
[TBL] [Abstract][Full Text] [Related]
20. Detecting potential safety issues in clinical trials by Bayesian screening.
Gould AL
Biom J; 2008 Oct; 50(5):837-51. PubMed ID: 18932142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
